Passage Bio Inc. (NASDAQ: PASG) Stock Information | RedChip

Passage Bio Inc. (NASDAQ: PASG) Listen to this Section


$0.77
-0.0104 ( -1.33% ) 99.6K

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

Market Data


Open


$0.77

Previous close


$0.78

Volume


99.6K

Market cap


$47.12M

Day range


$0.76 - $0.81

52 week range


$0.58 - $1.79

Insider Ownership Transactions

Total Amount Purchased: -1,485,557.00 | $ -1,143,284.67

Date Type Amount Purchased Purchaser
2024-05-23 Sale -47693.00 Islam Saqib
2024-05-23 Sale -47693.00 Porter Derrell
2024-05-23 Sale -39092.00 Sondhi Dolan
2024-05-23 Sale -47693.00 Countouriotis Athena
2024-05-23 Sale -47693.00 GOWEN MAXINE
2024-05-23 Sale -47693.00 Kapadia Sandip
2024-03-19 Sale -575000.00 Chou William
2024-03-19 Sale -203000.00 Forman Mark S
2024-03-19 Sale -227000.00 Borthwick Kathleen
2024-03-19 Sale -203000.00 Cale Edgar B.

SEC Fillings


Form Type Description Pages Date
3 Insider transactions 1 Aug 09, 2024
10-q Quarterly Reports 64 Aug 08, 2024
8-k 8K-related 45 Aug 08, 2024
8-k 8K-related 13 Aug 02, 2024
8-k 8K-related 15 Aug 01, 2024
8-k 8K-related 15 Jul 16, 2024
4 Insider transactions 1 May 23, 2024
4 Insider transactions 1 May 23, 2024
4 Insider transactions 1 May 23, 2024
4 Insider transactions 1 May 23, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.